4Bioengineering.com

Allergies are diseases in their fight against the pharmaceutical industry, despite generous patent granted privileges and monopoly profits so far made little progress. But it was now more in publicly funded research a step further.

Because of the origin of allergies so far almost nothing is known beyond the statistical correlations or spurious correlations, and it mainly in the field of medicine was apparent progress, the culture is non-allergenic animals and plants is becoming more significant.

However, the first known attempt proved in this direction as “vaporware”: in 2006 claimed that later in “Lifestyle Pets” renamed company Allerca that they produce on the lookout for a way, the gene, the cat, the allergic protein “Fel d 1″ allows to switch off or remove animals came on to produce a protein respond to people far less allergic.

Sheldon Spector of the University of California at Los Angeles, in the scientific journal Nature alleging that a study performed by him revealed that Allerca cats are actually less allergenic published, but so far neither the study nor the underlying data. He himself had doubts about the results of food by the method used by him later as “experimental” designated .

BIO Announces First Biotechnology Partnering in India Event

WASHINGTON, DC (Wednesday, June 16, 2010) The Biotechnology Industry Organization (BIO) a two-day listings annual biotechnology partnering meeting to Be Held in Hyderabad, India on September 21-22. The Association of Biotechnology Led Enterprises (ABLE), a national forum representing The Indian biotechnology That sector, Will participate way as the local host.

“This Is The first exclusive forum of Its Kind in India. This event Will Bring Together Biotechnology and pharmaceutical leaders to explore Business Opportunities with India’s life science companies,” Said Alan Eisenberg, BIO’s executive vice president of Emerging Companies and Business Development. “India’s biotech and pharmaceutical space IS world class, and the number and type of collaborations Between Indian and U.S. or U.S. Companies Has grown Rapidly in the Past Few Years. We are seeing year INcreased number of discovery-based deals and innovative structures, in addition to development alliances. So, Launching the Bio ® India International Partnering Conference Builds Tremendous Amount was of Existing activity led by Indian companies. ”

The meeting Will Bring Together Biotechnology and pharmaceutical companies from the U.S., Europe and Asia to explore potential partnerships and collaborations. Private one-on-one meetings Between investors, large biotech and pharmaceutical companies and Emerging Biotech Companies Will Be Indian arranged-through BIO’s new state-of-the-art software.

BIO Brings to India more Than Ten Years of experience and expertise in biotech and pharmaceutical partnering. BIO IS ITS renowned for Successful partnering meetings in the U.S., Japan and Germany, Including the World’s Largest biotech partnering event, the Business Forum at the BIO International Convention. ABLE, BIO’s partner in India, bring to the meeting extensive local expertise and Its comprehensive network of Indian and Asian biotech and pharmaceutical companies.